Neurofibromatosis Type 2 - 1 Studies Found
| Completed |
: Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity : Malignant Pleural Mesothelioma : 2009-12-02 : Drug: everolimus Everolimus will be administered at a dose of 10mg orally once daily continuously. Dose |